The author wishes to make the following correction to this paper [1]. Due to mislabeling, Figure 3 should be replaced with the following:

These changes have no material impact on the conclusions of our paper. The authors would like to apologize for any inconvenience caused to the readers by these changes.
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Lu J., Zhang J., Wang Y., Sun Q. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice. Int. J. Mol. Sci. 2018;19:1729. doi: 10.3390/ijms19061729. [DOI] [PMC free article] [PubMed] [Google Scholar]
